SMC guides and reports
General overview guides and reports on our work
SMC policies
Policies relating to our processes and procedures
- Guidance on medicines outwith remit (PDF, 243KB)
- Modifiers (PDF, 247KB)
- Biosimilar medicines (PDF, 223KB)
- Guide to quality adjusted life years (QALYs) (PDF, 425KB)
- Process for issuing not recommended advice due to non-submission (PDF, 228KB)
- Resubmission of medicines not recommended following consideration through PACE process (PDF, 567KB)
- Re-evaluation of SMC decisions (PDF, 261KB)
- Code of practice for declarations of interest (PDF, 188KB)
- Standard explanation of declarations of interest (PDF, 162KB)
SMC policies: company submissions
Our policies and procedures around submissions made by pharmaceutical companies
- Release of clinical, economic and indirect comparison checklists - overview (PDF, 219KB)
- Clinical checklist (DOCX, 29KB)
- Economic checklist (DOCX, 23KB)
- Indirect comparison - mixed treatment comparison checklist (DOC, 104KB)
- Matching Adjusted Indirect Comparison (MAIC) checklist (DOC, 97KB)
- Release of company data (PDF, 238KB)
- Meetings with companies post-SMC (PDF, 236KB)
Scottish Government policies
Policies set by Scotland's devolved government